Fig. 1From: Genome-wide analysis of DNA methylation identifies S100A13 as an epigenetic biomarker in individuals with chronic (≥ 30 years) type 2 diabetes without diabetic retinopathyThe distribution of differential methylation sites (DMSs). Red markers represent the hypermethylation sites of the DR group, and green markers represent the hypomethylation siteBack to article page